Identification of a Highly Antigenic Linear B Cell Epitope within Plasmodium vivax Apical Membrane Antigen 1 (AMA-1)
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
17/04/2012
17/04/2012
2011
|
Resumo |
Apical membrane antigen 1 (AMA-1) is considered to be a major candidate antigen for a malaria vaccine. Previous immunoepidemiological studies of naturally acquired immunity to Plasmodium vivax AMA-1 (PvAMA-1) have shown a higher prevalence of specific antibodies to domain II (DII) of AMA-1. In the present study, we confirmed that specific antibody responses from naturally infected individuals were highly reactive to both full-length AMA-1 and DII. Also, we demonstrated a strong association between AMA-1 and DII IgG and IgG subclass responses. We analyzed the primary sequence of PvAMA-1 for B cell linear epitopes co-occurring with intrinsically unstructured/ disordered regions (IURs). The B cell epitope comprising the amino acid sequence 290-307 of PvAMA-1 (SASDQPTQYEEEMTDYQK), with the highest prediction scores, was identified in domain II and further selected for chemical synthesis and immunological testing. The antigenicity of the synthetic peptide was identified by serological analysis using sera from P. vivax-infected individuals who were knowingly reactive to the PvAMA-1 ectodomain only, domain II only, or reactive to both antigens. Although the synthetic peptide was recognized by all serum samples specific to domain II, serum with reactivity only to the full-length protein presented 58.3% positivity. Moreover, IgG reactivity against PvAMA-1 and domain II after depletion of specific synthetic peptide antibodies was reduced by 18% and 33% (P = 0.0001 for both), respectively. These results suggest that the linear epitope SASDQPTQYEEEMTDYQK is highly antigenic during natural human infections and is an important antigenic region of the domain II of PvAMA-1, suggesting its possible future use in pre-clinical studies. Fundacao de Amparo a Pesquisa do Estado de Minas Gerais/FAPEMIG[CBB APQ-0997-4.01/07] CNPq/Brazil PNPD/CAPES Brazilian National Research Council (CNPq) Pro-Reitoria de Pesquisa of the Universidade Federal de Minas Gerais |
Identificador |
PLOS ONE, v.6, n.6, 2011 1932-6203 http://producao.usp.br/handle/BDPI/14812 10.1371/journal.pone.0021289 |
Idioma(s) |
eng |
Publicador |
PUBLIC LIBRARY SCIENCE |
Relação |
Plos One |
Direitos |
openAccess Copyright PUBLIC LIBRARY SCIENCE |
Palavras-Chave | #MALARIA VACCINE CANDIDATE #BLOOD-STAGE MALARIA #FALCIPARUM MALARIA #ERYTHROCYTE INVASION #ANTIBODY-RESPONSE #CLINICAL-TRIAL #FULL-LENGTH #DOMAIN-II #RECOMBINANT #PROTEIN #Biology #Multidisciplinary Sciences |
Tipo |
article original article publishedVersion |